Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

Florenzo Iannone, Lugi Sinigaglia, Ennio Giulio Favalli, Piercarlo Sarzi-Puttini, Fabiola Atzeni, Roberto Caporali, Veronica Codullo, G. Ferraccioli, Elisa Gremese, A. Carletto, Alessandro Giollo, M. Govoni, Francesca Bergossi, M. Galeazzi, L. Cantarini, F. Salaffi, Marco Di Carlo, Chiara Bazzani, Raffaele Pellerito, Marco SebastianiRoberta Ramonda, Giovanni Lapadula

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability'. Together they form a unique fingerprint.

Medicine & Life Sciences